Impaired adipose tissue expandability and lipogenic capacities as ones of the main causes of metabolic disorders

Journal of Diabetes Research

Volumn 2015, Issue , 2015, Pages

  Moreno Indias, Isabel ^a,b   Tinahones, Francisco José ^a,b  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DESATURASE; BRCA1 PROTEIN; FATTY ACID BINDING PROTEIN 4; FATTY ACID SYNTHASE; GLYCOPROTEIN; MICRORNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RAB PROTEIN; RAB18 PROTEIN; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; VASCULOTROPIN; ZINC ALPHA2 GLYCOPROTEIN;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANGIOGENESIS; APOPTOSIS; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; ENZYME ACTIVITY; HUMAN; INFLAMMATION; INSULIN RESISTANCE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; ANIMAL; COMORBIDITY; CYTOLOGY; HYPERTROPHY; LIPOGENESIS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY;

ADIPOCYTES; ADIPOGENESIS; ADIPOSE TISSUE; ANIMALS; APOPTOSIS; COMORBIDITY; HUMANS; HYPERTROPHY; INSULIN RESISTANCE; LIPOGENESIS; METABOLIC DISEASES; NEOVASCULARIZATION, PATHOLOGIC; OBESITY;

EID: 84928243640     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2015/970375     Document Type: Review

References (111)

1. M. Ng, T. Fleming, M. Robinson et al., "Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden ofDisease Study 2013,"TheLancet, vol. 384, no. 9945, pp. 766-781, 2014.
2. J. Chen, Y. Meng, J. Zhou et al., "Identifying candidate genes for type 2 diabetes mellitus and obesity through gene expression profiling in multiple tissues or cells," Journal of Diabetes Research, vol. 2013, Article ID 970435, 9 pages, 2013.
3. B.-C. Lee and J. Lee, "Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance," Biochimica et Biophysica Acta-Molecular Basis of Disease, vol. 1842, no. 3, pp. 446-462, 2014.
4. M. Bastien, P. Poirier, I. Lemieux, and J.-P. Després, "Overview of epidemiology and contribution of obesity to cardiovascular disease," Progress in Cardiovascular Diseases, vol. 56, no. 4, pp. 369-381, 2014.
5. R. Loomba and A. J. Sanyal, "The global NAFLD epidemic," Nature Reviews Gastroenterology and Hepatology, vol. 10, no. 11, pp. 686-690, 2013.
6. J. A. Ligibel, C. M. Alfano, K. S. Courneya et al., "American Society of Clinical Oncology position statement on obesity and cancer," Journal of Clinical Oncology, vol. 32, no. 31, pp. 3568-3574, 2014.
7. T. Fall and E. Ingelsson, "Genome-wide association studies of obesity and metabolic syndrome," Molecular and Cellular Endocrinology, vol. 382, no. 1, pp. 740-757, 2014.
8. E. Ginter and V. Simko, "Type 2 diabetes mellitus, pandemic in 21st century," Advances in Experimental Medicine and Biology, vol. 771, pp. 42-50, 2012.
9. D. Vistisen, D. R. Witte, A. G. Tabák et al., "Patterns of obesity development before the diagnosis of type 2 diabetes: the Whitehall II cohort study," PLoS Medicine, vol. 11, no. 2, Article ID e1001602, 2014.
10. S. A. Brethauer, A. Aminian, H. Romero-Talamás et al., "Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patientswith type 2 diabetes mellitus," Annals of Surgery, vol. 258, no. 4, pp. 628-636, 2013.
11. S. Lee, A. R. Deldin, D. White et al., "Aerobic exercise but not resistance exercise reduces intrahepatic lipid content and visceral fat and improves insulin sensitivity in obese adolescent girls: a randomized controlled trial," American Journal of Physiology: Endocrinology and Metabolism, vol. 305, no. 10, pp. E1222-E1229, 2013.
12. T. Romacho, M. Elsen, D. Röhrborn, and J. Eckel, "Adipose tissue and its role in organ crosstalk," Acta Physiologica, vol. 210, no. 4, pp. 733-753, 2014.
13. J.-P. Després and I. Lemieux, "Abdominal obesity and metabolic syndrome," Nature, vol. 444, no. 7121, pp. 881-887, 2006.
14. M. Blüher, "The distinction of metabolically 'healthy' from 'unhealthy' obese individuals," Current Opinion in Lipidology, vol. 21, no. 1, pp. 38-43, 2010.
15. P. Patel and N. Abate, "Body fat distribution and insulin resistance," Nutrients, vol. 5, no. 6, pp. 2019-2027, 2013.
16. I. Moreno-Indias, F. Cardona, F. J. Tinahones, and M. I. Queipo-Ortuño, "Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus," Frontiers in Microbiology, vol. 5, article 190, 2014.
17. M. Blüher, "Adipose tissue dysfunction contributes to obesity related metabolic diseases," Best Practice & Research: Clinical Endocrinology & Metabolism, vol. 27, no. 2, pp. 163-177, 2013.
18. L. Lionetti, M. P. Mollica, A. Lombardi, G. Cavaliere, G. Gifuni, and A. Barletta, "From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation," Nutrition, Metabolism and Cardiovascular Diseases, vol. 19, no. 2, pp. 146-152, 2009.
19. J. V. Neel, "Diabetes mellitus: a 'thrifty' genotype rendered detrimental by 'progress'" American Journal ofHumanGenetics, vol. 14, no. 4, pp. 353-362, 1962.
20. F. Ameer, L. Scandiuzzi, S. Hasnain, H. Kalbacher, and N. Zaidi, "De novo lipogenesis inhealthanddisease,"Metabolism:Clinical and Experimental, vol. 63, no. 7, pp. 895-902, 2014.
21. R. V. Farese Jr., R. Zechner, C. B. Newgard, and T. C. Walther, "The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance," Cell Metabolism, vol. 15, no. 5, pp. 570-573, 2012.
22. G. Boden, P. Cheung, K. Kresge, C. Homko, B. Powers, and L. Ferrer, "Insulin resistance is associated with diminished endoplasmic reticulum stress responses in adipose tissue of healthy and diabetic subjects," Diabetes, vol. 63, no. 9, pp. 2977-2983, 2014.
23. S. Pereira, D. M. Breen, A. E. Naassan et al., "In vivo effects of polyunsaturated,monounsaturated, and saturated fatty acids on hepatic and peripheral insulin sensitivity," Metabolism: Clinical and Experimental, vol. 64, no. 2, pp. 315-322, 2015.
24. J. Boon, A. J. Hoy, R. Stark et al., "Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance," Diabetes, vol. 62, no. 2, pp. 401-410, 2013.
25. I. J. Lodhi, L. Yin, A. P. L. Jensen-Urstad et al., "Inhibiting adipose tissue lipogenesis reprograms thermogenesis and PPAR activation to decrease diet-induced obesity," Cell Metabolism, vol. 16, no. 2, pp. 189-201, 2012.
26. K. Minehira, N. Vega, H. Vidal, K. Acheson, and L. Tappy, "Effect of carbohydrate overfeeding on whole bodymacronutrientmetabolism and expression of lipogenic enzymes in adipose tissue of lean and overweight humans," International Journal of Obesity, vol. 28, no. 10, pp. 1291-1298, 2004.
27. R. H. Unger, G. O. Clark, P. E. Scherer, and L. Orci, "Lipid homeostasis, lipotoxicity and the metabolic syndrome," Biochimica et Biophysica Acta, vol. 1801, no. 3, pp. 209-214, 2010.
28. F. J. Ortega, D. Mayas, J. M. Moreno-Navarrete et al., "The gene expression of the main lipogenic enzymes is downregulated in visceral adipose tissue of obese subjects," Obesity, vol. 18, no. 1, pp. 13-20, 2010.
29. O. Poulain-Godefroy, C. Lecoeur, F. Pattou, G. Frühbeck, and P. Froguel, "Inflammation is associated with a decrease of lipogenic factors in omental fat in women," American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 295, no. 1, pp. R1-R7, 2008.
30. J. Chen, Y. Meng, J. Zhou et al., "Identifying candidate genes for type 2 diabetes mellitus and obesity through gene expression profiling in multiple tissues or cells," Journal of Diabetes Research, vol. 2013, Article ID 970435, 9 pages, 2013.
31. M. P. Keller and A. D. Attie, "Physiological insights gained from gene expression analysis in obesity and diabetes," Annual Review of Nutrition, vol. 30, pp. 341-364, 2010.
32. T.-A. Cock, S. M. Houten, and J. Auwerx, "Peroxisome proliferator-activated receptor-: too much of a good thing causes harm," EMBO Reports, vol. 5, no. 2, pp. 142-147, 2004.
33. M. Macias-Gonzalez, F. Cardona, M. Queipo-Ortuño, R. Bernal, M. Martin, and F. J. Tinahones, "PPAR mRNA expression is reduced in peripheral blood mononuclear cells after fat overload in patients with metabolic syndrome," Journal ofNutrition, vol. 138, no. 5, pp. 903-907, 2008.
34. S. Rodriguez-Cuenca, S. Carobbio, V. R. Velagapudi et al., "Peroxisome proliferator-activated receptor gamma-dependent regulation of lipolytic nodes and metabolic flexibility," Molecular and Cellular Biology, vol. 32, no. 8, pp. 1555-1565, 2012.
35. E. Garcia-Fuentes,M. Murri, L. Garrido-Sanchez et al., "PPAR expression after a high-fatmeal is associated with plasma superoxide dismutase activity in morbidly obese persons," Obesity, vol. 18, no. 5, pp. 952-958, 2010.
36. M. MacIas-Gonzalez, I. Moreno-Santos, J. M. Garcá-Almeida, F. J. Tinahones, and E. Garcia-Fuentes, "PPAR2 protects against obesity by means of a mechanism that mediates insulin resistance," European Journal of Clinical Investigation, vol. 39, no. 11, pp. 972-979, 2009.
37. B. M. Spiegelman, "PPAR-gamma: adipogenic regulator and thiazolidinedione receptor," Diabetes, vol. 47, no. 4, pp. 507-514, 1998.
38. F. B. Hillgartner, L. M. Salati, and A. G. Goodridge, "Physiological and molecular mechanisms involved in nutritional regulation of fatty acid synthesis," Physiological Reviews, vol. 75, no. 1, pp. 47-76, 1995.
39. M. D. Mayas, F. J. Ortega, M. MacÍas-Gonzlez et al., "Inverse relation between FASN expression in human adipose tissue and the insulin resistance level," Nutrition & Metabolism, vol. 7, article 3, 2010.
40. M. D. Mayas, F. J. Ortega, R. Gómez-Huelgas, N. Roca, J. M. Fernández-Real, and F. J. Tinahones, "Decrease in FASNexpression in adipose tissue of hypertensive individuals," American Journal of Hypertension, vol. 22, no. 12, pp. 1258-1262, 2009.
41. A. Cabassi and S. Tedeschi, "Zinc-2-glycoprotein as a marker of fat catabolism in humans," Current Opinion in Clinical Nutrition and Metabolic Care, vol. 16, no. 3, pp. 267-271, 2013.
42. S. T. Russell, T. P. Zimmerman, B. A. Domin, and M. J. Tisdale, "Induction of lipolysis in vitro and loss of body fat in vivo by zinc-2-glycoprotein," Biochimica et Biophysica Acta, vol. 1636, no. 1, pp. 59-68, 2004.
43. L. Garrido-Sánchez, E. Garcá-Fuentes, D. Fernández-Garcá et al., "Zinc-alpha 2-glycoprotein gene expression in adipose tissue is related with insulin resistance and lipolytic genes in morbidly obese patients," PLoS ONE, vol. 7, no. 3, Article ID e33264, 2012.
44. L. Makowski and G. S. Hotamisligil, "Fatty acid binding proteins-the evolutionary crossroads of inflammatory and metabolic responses," The Journal of Nutrition, vol. 134, no. 9, pp. 2464s-2468s, 2004.
45. M. I. Queipo-Ortuño, X. Escoté, V. Ceperuelo-Mallafré et al., "FABP4 dynamics in obesity: discrepancies in adipose tissue and liver expression regarding circulating plasma levels," PLoS ONE, vol. 7, no. 11,Article ID e48605, 2012.
46. B. Sánchez-Solana, J. Laborda, and V. Baladrón, "Mouse resistin modulates adipogenesis and glucose uptake in 3T3-L1 preadipocytes through the ROR1 receptor," Molecular Endocrinology, vol. 26, no. 1, pp. 110-127, 2012.
47. B. Meissburger, J. Ukropec, E. Roeder et al., "Adipogenesis and insulin sensitivity in obesity are regulated by retinoid-related orphan receptor gamma," EMBOMolecularMedicine, vol. 3, no. 11, pp. 637-651, 2011.
48. F. J. Tinahones, I. Moreno-Santos, J. Vendrell et al., "The retinoic acid receptor-related orphan nuclear receptor 1 (ROR1): a novel player determinant of insulin sensitivity in morbid obesity," Obesity, vol. 20, no. 3, pp. 488-497, 2012.
49. M. T. Flowers and J. M. Ntambi, "Stearoyl-CoA desaturase and its relation to high-carbohydrate diets and obesity," Biochimica et Biophysica Acta, vol. 1791, no. 2, pp. 85-91, 2009.
50. D. Mauvoisin and C. Mounier, "Hormonal and nutritional regulation of SCD1 gene expression," Biochimie, vol. 93, no. 1, pp. 78-86, 2011.
51. J. M. Ntambi, M. Miyazaki, J. P. Stoehr et al., "Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity," Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 17, pp. 11482-11486, 2002.
52. S. Garcá-Serrano, I. Moreno-Santos, L. Garrido-Sánchez et al., "Stearoyl-CoA desaturase-1 is associated with insulin resistance in morbidly obese subjects,"MolecularMedicine, vol. 17, no. 3-4, pp. 273-280, 2011.
53. S. Carobbio, R. M. Hagen, C. J. Lelliott et al., "Adaptive changes of the Insig1/SREBP1/SCD1 set point help adipose tissue to cope with increased storage demands of obesity," Diabetes, vol. 62,no. 11, pp. 3697-3708, 2013.
54. S. Martin and R. G. Parton, "Lipid droplets: a unified view of a dynamic organelle," Nature Reviews Molecular Cell Biology, vol. 7, no. 5, pp. 373-378, 2006.
55. M. R. Pulido, A. Diaz-Ruiz, Y. Jiménez-Gómez et al., "Rab18 dynamics in adipocytes in relation to lipogenesis, lipolysis and obesity," PLoS ONE, vol. 6, no. 7, Article ID e22931, 2011.
56. S. Martin, K. Driessen, S. J. Nixon, M. Zerial, and R. G. Parton, "Regulated localization of Rab18 to lipid droplets: effects of lipolytic stimulation and inhibition of lipid droplet catabolism," The Journal of Biological Chemistry, vol. 280, no. 51, pp. 42325-42335, 2005.
57. M. R. Pulido, Y. Rabanal-Ruiz, F. Almabouada et al., "Nutritional, hormonal, and depot-dependent regulation of the expression of the small GTPase Rab18 in rodent adipose tissue," Journal of Molecular Endocrinology, vol. 50, no. 1, pp. 19-29, 2013.
58. S. J. Hill, T. Rolland, G. Adelmant et al., "Systematic screening reveals a role for BRCA1 in the response to transcriptionassociated DNA damage," Genes & Development, vol. 28, no. 17, pp. 1957-1975, 2014.
59. M. Song, K. Hakala, S. T. Weintraub, and Y. Shiio, "Quantitative proteomic identification of the BRCA1 ubiquitination substrates," Journal of Proteome Research, vol. 10,no. 11,pp. 5191-5198, 2011.
60. H. Ray, K. Moreau, E. Dizin, I. Callebaut, and N. D. Venezia, "ACCA phosphopeptide recognition by the BRCT repeats of BRCA1," Journal of Molecular Biology, vol. 359, no. 4, pp. 973-982, 2006.
61. F. J. Ortega, J. M. Moreno-Navarrete, D. Mayas et al., "Breast cancer 1 (BrCa1) may be behind decreased lipogenesis in adipose tissue fromobese subjects," PLoS ONE, vol. 7, no. 5,Article ID e33233, 2012.
62. G. H. Goossens, "The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance," Physiology& Behavior, vol. 94, no. 2, pp. 206-218, 2008.
63. K. L. Spalding, E. Arner, P. O. Westermark et al., "Dynamics of fat cell turnover in humans," Nature, vol. 453, no. 7196, pp. 783-787, 2008.
64. S. de Ferranti and D. Mozaffarian, "The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences," Clinical Chemistry, vol. 54, no. 6, pp. 945-955, 2008.
65. R. Drolet, C. Richard, A. D. Sniderman et al., "Hypertrophy and hyperplasia of abdominal adipose tissues in women," International Journal of Obesity, vol. 32, no. 2, pp. 283-291, 2008.
66. M. M. Ibrahim, "Subcutaneous and visceral adipose tissue: structural and functional differences," Obesity Reviews, vol. 11, no. 1, pp. 11-18, 2010.
67. J. Hoffstedt, E. Arner, H. Wahrenberg et al., "Regional impact of adipose tissue morphology on the metabolic profile in morbid obesity," Diabetologia, vol. 53, no. 12, pp. 2496-2503, 2010.
68. A. Veilleux, M. Caron-Jobin, S. Nöel, P. Y. Laberge, and A. Tchernof, "Visceral adipocyte hypertrophy is associated with dyslipidemia independent of body composition and fat distribution in women," Diabetes, vol. 60, no. 5, pp. 1504-1511, 2011.
69. F. J. Tinahones, L. Garrido-Sanchez,M. Miranda et al., "Obesity and insulin resistance-related changes in the expression of lipogenic and lipolytic genes in morbidly obese subjects," Obesity Surgery, vol. 20, no. 11, pp. 1559-1567, 2010.
70. C. Y. Tan and A. Vidal-Puig, "Adipose tissue expandability: the metabolic problems of obesity may arise from the inability to become more obese," Biochemical Society Transactions, vol. 36, no. 5, pp. 935-940, 2008.
71. S. Virtue and A. Vidal-Puig, "Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome-an allostatic perspective," Biochimica et Biophysica Acta-Molecular and Cell Biology of Lipids, vol. 1801, no. 3, pp. 338-349, 2010.
72. J. K. Sethi and A. J. Vidal-Puig, "Thematic review series: adipocyte Biology. Adipose tissue function and plasticity orchestrate nutritional adaptation," Journal of Lipid Research, vol. 48, no. 6, pp. 1253-1262, 2007.
73. M. Laudes, "Role of WNT signalling in the determination of human mesenchymal stem cells into preadipocytes," Journal of Molecular Endocrinology, vol. 46, no. 2, pp. R65-R72, 2011.
74. S. E. Jones and C. Jomary, "Secreted Frizzled-related proteins: searching for relationships and patterns," BioEssays, vol. 24, no. 9, pp. 811-820, 2002.
75. A. Ehrlund, N. Mejhert, S. Lorente-Cebrián et al., "Characterization of the Wnt inhibitors secreted frizzled-related proteins (SFRPs) in human adipose tissue," Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 3, pp. E503-E508, 2013.
76. N. Ouchi, A. Higuchi, K. Ohashi et al., "Sfrp5 is an antiinflammatory adipokine that modulates metabolic dysfunction in obesity," Science, vol. 329, no. 5990, pp. 454-457, 2010.
77. C. Lagathu, C. Christodoulides, C. Y. Tan et al., "Secreted frizzled-related protein 1 regulates adipose tissue expansion and is dysregulated in severe obesity," International Journal of Obesity, vol. 34, no. 12, pp. 1695-1705, 2010.
78. F. J. Ortega, A. Vazquez-Martin, J.-M. Moreno-Navarrete et al., "Thyroid hormone responsive Spot 14 increases during differentiation of human adipocytes and its expression is downregulated in obese subjects," International Journal of Obesity, vol. 34, no. 3, pp. 487-499, 2010.
79. S. Baglioni,M. Francalanci, R. Squecco et al., "Characterization of human adult stem-cell populations isolated from visceral and subcutaneous adipose tissue,"TheFASEB Journal, vol. 23,no. 10, pp. 3494-3505, 2009.
80. P. Isakson, A. Hammarstedt, B. Gustafson, and U. Smith, "Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosis factor-, and inflammation," Diabetes, vol. 58, no. 7, pp. 1550-1557, 2009.
81. K. Cleveland-Donovan, L. A. Maile,W. G. Tsiaras, T. Tchkonia, J. L. Kirkland, and C. M. Boney, "IGF-I activation of the AKT pathway is impaired in visceral but not subcutaneous preadipocytes from obese subjects," Endocrinology, vol. 151, no. 8, pp. 3752-3763, 2010.
82. M. Roldan,M. Macias-Gonzalez, R. Garcia, F. J. Tinahones, and M. Martin, "Obesity short-circuits stemness gene network in human adiposemultipotent stemcells," The FASEB Journal, vol. 25, no. 12, pp. 4111-4126, 2011.
83. S. Virtue and A. Vidal-Puig, "It's not how fat you are, it's what you do with it that counts," PLoS Biology, vol. 6, no. 9, article e237, 2008.
84. A. Sorisky, "Clinical implications of adipose tissue remodelling: adipogenesis and apoptosis," Canadian Journal of Diabetes, vol. 26, no. 3, pp. 232-240, 2002.
85. S. Cinti, G. Mitchell, G. Barbatelli et al., "Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans," Journal of Lipid Research, vol. 46, no. 11, pp. 2347-2355, 2005.
86. M. Keuper, M. Blüher, M. R. Schön et al., "An inflammatory micro-environment promotes human adipocyte apoptosis," Molecular and Cellular Endocrinology, vol. 339, no. 1-2, pp. 105-113, 2011.
87. P. Arner and K. L. Spalding, "Fat cell turnover in humans," Biochemical and Biophysical Research Communications, vol. 396, no. 1, pp. 101-104, 2010.
88. F. J. Tinahones, L. C. Aragüez, M. Murri et al., "Caspase induction and BCL2 inhibition in human adipose tissue: a potential relationship with insulin signaling alteration," Diabetes Care, vol. 36, no. 3, pp. 513-521, 2013.
89. M. R. Chacón, C. Richart, J. M. Gómez et al., "Expression of TWEAK and its receptor Fn14 in human subcutaneous adipose tissue. Relationship with other inflammatory cytokines in obesity," Cytokine, vol. 33, no. 3, pp. 129-137, 2006.
90. J. Vendrell, E. Maymó-Masip, F. Tinahones et al., "Tumor necrosis-like weak inducer of apoptosis as a proinflammatory cytokine in human adipocyte cells: up-regulation in severe obesity ismediated by inflammation but not hypoxia," Journal of Clinical Endocrinology andMetabolism, vol. 95, no. 6, pp. 2983-2992, 2010.
91. E. Maymó-Masip, S. Fernández-Veledo, A. G. España et al., "The rise of soluble TWEAK levels in severely obese subjects after bariatric surgery may affect adipocyte-cytokine production induced by TNF," The Journal of Clinical Endocrinology & Metabolism, vol. 98, no. 8, pp. E1323-E1333, 2013.
92. S. Bernardi, G. Zauli, C. Tikellis et al., "TNF-related apoptosisinducing ligand significantly attenuates metabolic abnormalities in high-fat-fed mice reducing adiposity and systemic inflammation," Clinical Science, vol. 123, no. 9,pp. 547-555, 2012.
93. H. H. Harith,M. J. Morris, andM. M. Kavurma, "Onthe TRAIL of obesity and diabetes," Trends in Endocrinology&Metabolism, vol. 24, no. 11, pp. 578-587, 2013.
94. M. Keuper, I. Wernstedt Asterholm, P. E. Scherer et al., "TRAIL (TNF-related apoptosis-inducing ligand) regulates adipocyte metabolism by caspase-mediated cleavage of PPARgamma," Cell death & disease, vol. 4, article e474, 2013.
95. S. Ledoux, I. Queguiner, S. Msika et al., "Angiogenesis associated with visceral and subcutaneous adipose tissue in severe human obesity," Diabetes, vol. 57, no. 12, pp. 3247-3257, 2008.
96. Y. Cao, "Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases," Nature ReviewsDrugDiscovery, vol. 9, no. 2, pp. 107-115, 2010.
97. S. Wang, X. Li, M. Parra, E. Verdin, R. Bassel-Duby, and E. N. Olson, "Control of endothelial cell proliferation and migration by VEGF signaling to histone deacetylase 7," Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 22, pp. 7738-7743, 2008.
98. H.-K. Sung, K.-O. Doh, J. E. Son et al., "Adipose vascular endothelial growth factor regulates metabolic homeostasis through angiogenesis," Cell Metabolism, vol. 17, no. 1, pp. 61-72, 2013.
99. A. Saiki, F. Watanabe, T. Murano, Y. Miyashita, and K. Shirai, "Hepatocyte growth factor secreted by cultured adipocytes promotes tube formation of vascular endothelial cells in vitro," International Journal of Obesity, vol. 30, no. 11, pp. 1676-1684, 2006.
100. I. Elias, S. Franckhauser, T. Ferré et al., "Adipose tissue overexpression of vascular endothelial growth factor protects against diet-induced obesity and insulin resistance," Diabetes, vol. 61, no. 7, pp. 1801-1813, 2012.
101. F. J. Tinahones, L. Có?n-Aragüez, M. D. Mayas et al., "Obesityassociated insulin resistance is correlated to adipose tissue vascular endothelial growth factors and metalloproteinase levels," BMC Physiology, vol. 12, no. 1, article 4, 2012.
102. H. Wada, S. Ura, S. Kitaoka et al., "Distinct characteristics of circulating vascular endothelial growth factor-A and C levels in human subjects," PLoS ONE, vol. 6, no. 12, Article ID e29351, 2011.
103. P. D. Cani, J. Amar,M. A. Iglesias et al., "Metabolic endotoxemia initiates obesity and insulin resistance," Diabetes, vol. 56, no. 7, pp. 1761-1772, 2007.
104. M. Clemente-Postigo, M. I. Queipo-Ortuño, M. Murri et al., "Endotoxin increase after fat overload is related to postprandial hypertriglyceridemia in morbidly obese patients," Journal of Lipid Research, vol. 53, no. 5, pp. 973-978, 2012.
105. A. M. Caricilli and M. J. A. Saad, "The role of gut microbiota on insulin resistance," Nutrients, vol. 5, no. 3, pp. 829-851, 2013.
106. N. Barbarroja, R. López-Pedrera,M. D. Mayas et al., "The obese healthy paradox: is inflammation the answer" The Biochemical Journal, vol. 430, no. 1, pp. 141-149, 2010.
107. N. Hosogai, A. Fukuhara, K. Oshima et al., "Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation," Diabetes, vol. 56, no. 4, pp. 901-911, 2007.
108. J. Ye, "Emerging role of adipose tissue hypoxia in obesity and insulin resistance," International Journal of Obesity, vol. 33, no. 1, pp. 54-66, 2009.
109. P. Trayhurn, B. Wang, and I. S. Wood, "Hypoxia and the endocrine and signalling role of white adipose tissue," Archives of Physiology and Biochemistry, vol. 114, no. 4, pp. 267-276, 2008.
110. J. Ye, "Mechanisms of insulin resistance in obesity," Frontiers of Medicine in China, vol. 7, no. 1, pp. 14-24, 2013.
111. J. Ye andO. P. McGuinness, "Inflammation during obesity is not all bad: evidence from animal and human studies," American Journal of Physiology: Endocrinology and Metabolism, vol. 304, no. 5, pp. E466-E477, 2013.